Lucy Cook’s Post

Zynex (Nasdaq: ZYXI) CEO Thomas Sandgaard reflects on a successful 2024 and outlines plans for 2025 after hitting a major revenue milestone! 🎯 In 2024, Zynex hit a major milestone, reaching $200 million in revenue while staying profitable. New products, like braces, cold therapy devices, and advancements in pain management, played a key role in this success. Looking ahead to 2025, Zynex forecasts 10–15% revenue growth, with a focus on expanding territories and innovation. Zynex's laser-based pulse oximeter, set for FDA submission, promises to revolutionize monitoring, particularly for patients with darker skin tones. 🌟 Employee satisfaction and award-winning workplace culture will continue to drive Zynex’s growth as they aim to potentially double EBITDA and earnings per share. Watch the interview and read the entire article to learn more by clicking the following link: https://lnkd.in/gEh74CYh Zynex Medical | Zynex Monitoring Solutions | Nasdaq | $ZYXI

📢Revolutionary Magnetic Mixer Solves Manufacturing Challenges 📢 Cytiva has introduced its Xcellerex magnetic mixer at the Interphex meeting in New York City. 🔬 The mixer is designed to address challenges faced by customers in large-scale manufacturing processes. 🌐 It comes in 2000 and 3000 L capacities, with flexible configurations to cater to diverse mixing processes. 💧 The mixer's design prevents leaks, reducing time and money losses. 🌀 The impeller and hexagonal shape of the mixer create a vortex that improves the mixing process. 💼 The compact size of the mixer allows it to fit into tight facility spaces without compromising capacity. 🚀 Cytiva aims to quickly get life-changing therapies to patients by addressing customer challenges. #BioprocessUpdates #Cytiva #Xcellerex #magneticmixer #Interphex #manufacturing #mixingprocess #leakprevention #vortex #facilities #lifetherapies #customersatisfaction #innovation #technology #patientcare #pharmaceuticals ▷ Read the full article here: 📎 https://lnkd.in/dAyuibX8

You better believe it! AND… BENEV Exosomes have become the chosen Exosome brand by over 250,000 offices in the US! Boasting 30+ clinical studies, 6 US patents and over 20 years of research and development, you can rely on the proven efficacy and purity of our products. Double tap if you're loving the science-backed beauty of BENEV Exosomes! #benevexosomes #exosomeregenerativecomplex #exosometechnology *Disclaimer: BENEV Exosome Regenerative Complexes are not drug products. They are not intended to prevent, treat, or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously.

𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗕𝗶𝗼-𝗜𝗧 𝗪𝗼𝗿𝗹𝗱 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 & 𝗘𝘅𝗽𝗼 𝟮𝟬𝟮𝟰! Reflecting on an exciting week, we share some key moments from our time in Boston: Mario Torchia's poster presentation "𝘋𝘦𝘮𝘰𝘤𝘳𝘢𝘵𝘪𝘻𝘪𝘯𝘨 𝘵𝘩𝘦 𝘜𝘴𝘦 𝘰𝘧 𝘔𝘰𝘥𝘦𝘭𝘪𝘯𝘨 𝘢𝘯𝘥 𝘚𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯 𝘸𝘪𝘵𝘩 𝘐𝘯𝘚𝘪𝘭𝘪𝘤𝘰𝘛𝘳𝘪𝘢𝘭𝘴' 𝘉𝘪𝘰𝘴𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯 𝘗𝘭𝘢𝘵𝘧𝘰𝘳𝘮" sparked discussions on our #biosimulation platform. 🤝 Our team (Michael Eckstut, MaryAnne Rizk, Ph.D. and Mario Torchia) engaged with passionate professionals like Nimita Limaye across the #lifesciences, #pharmaceuticals and #healthcare sectors, further fueling our mission to revolutionize #drugdevelopment through the use of #insilico technology. 📘 We also had the chance to feature the book "𝘛𝘰𝘸𝘢𝘳𝘥 𝘎𝘰𝘰𝘥 𝘚𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯 𝘗𝘳𝘢𝘤𝘵𝘪𝘤𝘦" co-edited by our CEO Luca Emili, highlighting a consolidated set of industrial practices that render the development and use of #insilicotrials solutions easier and reliable. 🔽 Download the book and get in touch to find out how companies are already leveraging #modelingandsimulation to accelerate #medical innovation, reducing time and costs of specific R&D activities by up to 90%—all while upholding the highest standards of #patientsafety: https://lnkd.in/d-s6PY-f

3D-Printed Organs Market is experiencing new opportunities & competitive edge highlighted by Top Market Key Players (Organovo Holdings Inc., Modern Meadow, Poietis, REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc.) | Forecast to 2030 https://lnkd.in/eGyeNvVt #marketanalysis #marketresearch #marketresearchreports #businessintelligence

Advance your practice with BENEV Exosomes technology! 🔬 👉ExoCoBio has invested over $25 million in a cutting-edge GMP facility, guaranteeing the highest quality, stability, and purification of Exosomes. With over 1,000,000 patients treated, 6+ US patents, and an exclusive INCI name, our excellence is unmatched. Shoutout to Michael Gold, MD, FAAD, (@goldskincarecenter) for emphasizing the transformative potential of Exosomes ✨ #benevexosomes #exosomeregenerativecomplex #erc #erc+ #benevskinscience #exosome #exosometechnology #exosometreatment *Disclaimer: BENEV Exosome Regenerative Complexes are not drug products. They are not intended to prevent, treat, or cure diseases or medical conditions. They are not intended to be injected or delivered

The best place to network for manufacturers and suppliers? 🤝 #COMPAMED, of course! BYTEC Medizintechnik GmbH revealed this to us in an interview. 💬 What do you like most about COMPAMED? 👉 Check out the full report (link in the comments)!

ZwickRoell, a global leader in materials testing technology, is excited to announce a new strategic partnership with Cormica MET, an FDA-compliant testing laboratory. For daily news and analysis subscribe to the https://lnkd.in/gMvjgf3u newsletter. #Medtech #Healthcare #Innovation

Securecell is a proud sponsor of the 2024 #SwissBiotechDay (SBD) in Basel, organized by the Swiss Biotech Association. When attending the SBD, don’t miss out on visiting our booth (#80) and its neighboring coffee bike! And don’t forget to join the panel discussion on “Bioprocessing: The Next Generation. How to meet the challenges of new therapeutics, cost pressure, and big data?” which will be hosted by Christian Walter, Managing Director with Toolpoint. The discussion will be held Tuesday, 23 April 2024 (Panel 19 on “Lab Automation”), starting at 12:15 pm. On the panel, Andreas K., Head of Key Account Management with Securecell will be accompanied by Daniel Egger, Global Marketing Manager with Hamilton, Bachir EL DEBS, Director of High Throughput Biologics R&D with Lonza, and Samantha Paoletti, Head of Research and BD Life Science Technologies, CSEM.   We look forward to sharing Securecell’s vision of how our industry may further contribute to the improvement of biotechnologically manufactured products in different industrial sectors. To schedule an insightful conversation, please reach out to our representatives and arrange your in-person meeting with Andreas K. and Pascal Vonlanthen via this link: https://lnkd.in/eeghDgV2 #bioprocessing #digitalization #industry40 #bioreactor #automation #datamanagement #bioprocess_software #scadasoftware #PAT #lucullus #numera #IntegraOne

The best place to network for manufacturers and suppliers? 🤝 #COMPAMED, of course! BYTEC Medizintechnik GmbH revealed this to us in an interview. 💬 What do you like most about COMPAMED? 👉 Check out the full report (link in the comments)!